UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Modifiers of Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: A Systematic Review and Meta-Analysis

JNCI : Journal of the National Cancer Institute, 2014-06, Vol.106 (6), p.dju091-dju091

2014

Volltextzugriff (PDF)

American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer Susceptibility

Journal of clinical oncology, 2015-11, Vol.33 (31), p.3660-3667

2015

Volltextzugriff (PDF)

Update on Genetic Testing in Gynecologic Cancer

Journal of clinical oncology, 2019-09, Vol.37 (27), p.2501-2509

2019

Volltextzugriff (PDF)

BRCA Challenge: BRCA Exchange as a global resource for variants in BRCA1 and BRCA2

PLoS genetics, 2018-12, Vol.14 (12), p.e1007752-e1007752

2018

Volltextzugriff (PDF)

Genomic Signatures Predict the Immunogenicity of BRCA-Deficient Breast Cancer

Clinical cancer research, 2019-07, Vol.25 (14), p.4363-4374

2019

Volltextzugriff (PDF)

Changes in Cardiovascular Biomarkers With Breast Cancer Therapy and Associations With Cardiac Dysfunction

Journal of the American Heart Association, 2020-01, Vol.9 (2), p.e014708

2020

Volltextzugriff (PDF)

Cancer treatment according to BRCA1 and BRCA2 mutations

Nature reviews. Clinical oncology, 2012-09, Vol.9 (9), p.520-528

2012

Volltextzugriff (PDF)

Identification of BRCA1/2 mutation female carriers using circulating microRNA profiles

Nature communications, 2023-06, Vol.14 (1), p.3350-3350, Article 3350

2023

Volltextzugriff (PDF)

Risk-Reducing Mastectomy in BRCA1 and BRCA2 Mutation Carriers: A Complex Discussion

JAMA : the journal of the American Medical Association, 2019-01, Vol.321 (1), p.27

Domchek, Susan M.

2019

Volltextzugriff (PDF)

Analysis of matched primary and recurrent BRCA1/2 mutation-associated tumors identifies recurrence-specific drivers

Nature communications, 2022-11, Vol.13 (1), p.6728-19, Article 6728

2022

Volltextzugriff (PDF)

Central nervous system metastases in women who receive trastuzumab‐based therapy for metastatic breast carcinoma

Cancer, 2003-06, Vol.97 (12), p.2972-2977

2003

Volltextzugriff (PDF)

Variants at 6q21 implicate PRDM1 in the etiology of therapy-induced second malignancies after Hodgkin's lymphoma

Nature medicine, 2011-08, Vol.17 (8), p.941-943

2011

Volltextzugriff (PDF)

Immunotherapy for Breast Cancer: What Are We Missing?

Clinical cancer research, 2017-06, Vol.23 (11), p.2640-2646

2017

Volltextzugriff (PDF)

The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk

NPJ breast cancer, 2017-06, Vol.3 (1), p.22-10, Article 22

2017

Volltextzugriff (PDF)

Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study

The lancet oncology, 2006-03, Vol.7 (3), p.223-229

2006

Volltextzugriff (PDF)

Reversion Mutations with Clinical Use of PARP Inhibitors: Many Genes, Many Versions

Cancer discovery, 2017-09, Vol.7 (9), p.937-939

Domchek, Susan M

2017

Volltextzugriff (PDF)

Germline genetic testing for breast cancer: which patients? What genes?

Genetics in medicine, 2020-04, Vol.22 (4), p.698-700

Domchek, Susan M.

2020

Volltextzugriff (PDF)

Meta-analysis of Risk Reduction Estimates Associated With Risk-Reducing Salpingo-oophorectomy in BRCA1 or BRCA2 Mutation Carriers

JNCI : Journal of the National Cancer Institute, 2009-01, Vol.101 (2), p.80-87

2009

Volltextzugriff (PDF)

CDH1 on Multigene Panel Testing: Look Before You Leap

JNCI : Journal of the National Cancer Institute, 2020-04, Vol.112 (4), p.330-334

2020

Volltextzugriff (PDF)

Therapeutic approaches for women predisposed to breast cancer

Annual review of medicine, 2011-02, Vol.62 (1), p.295-306

2011

Volltextzugriff (PDF)

Comparison of up-front cash cards and checks as incentives for participation in a clinician survey: a study within a trial

BMC medical research methodology, 2020-08, Vol.20 (1), p.210-210, Article 210

2020

Volltextzugriff (PDF)

Toward Application of Polygenic Risk Scores to Both Enhance and Deintensify Breast Cancer Screening

Journal of clinical oncology, 2024-05, Vol.42 (13), p.1462-1465

2024

Volltextzugriff (PDF)

Stumbling blocks on the path to personalized medicine in breast cancer: the case of PARP inhibitors for BRCA1/2-associated cancers

Cancer discovery, 2011-06, Vol.1 (1), p.29-34

2011

Volltextzugriff (PDF)

Population Frequency of Germline BRCA1/2 Mutations

Journal of clinical oncology, 2016-12, Vol.34 (34), p.4183-4185

2016

Volltextzugriff (PDF)

1 – 25 von 374

Suche als RSS-Feed

Aktive Filter

ThemaAged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(362)
Mit Volltextzugriff
(307)

Publikationsform

Artikel
(372)
Buchkapitel
(2)

Sprache

Englisch
(374)
Japanisch
(26)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Modifiers of Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: A Systematic Review and Meta-Analysis

American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer Susceptibility

Update on Genetic Testing in Gynecologic Cancer

BRCA Challenge: BRCA Exchange as a global resource for variants in BRCA1 and BRCA2

Genomic Signatures Predict the Immunogenicity of BRCA-Deficient Breast Cancer

Changes in Cardiovascular Biomarkers With Breast Cancer Therapy and Associations With Cardiac Dysfunction

Cancer treatment according to BRCA1 and BRCA2 mutations

Identification of BRCA1/2 mutation female carriers using circulating microRNA profiles

Risk-Reducing Mastectomy in BRCA1 and BRCA2 Mutation Carriers: A Complex Discussion

Analysis of matched primary and recurrent BRCA1/2 mutation-associated tumors identifies recurrence-specific drivers

Central nervous system metastases in women who receive trastuzumab‐based therapy for metastatic breast carcinoma

Variants at 6q21 implicate PRDM1 in the etiology of therapy-induced second malignancies after Hodgkin's lymphoma

Immunotherapy for Breast Cancer: What Are We Missing?

The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk

Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study

Reversion Mutations with Clinical Use of PARP Inhibitors: Many Genes, Many Versions

Protocol to evaluate sequential electronic health record-based strategies to increase genetic testing for breast and ovarian cancer risk across diverse patient populations in gynecology practices

Germline genetic testing for breast cancer: which patients? What genes?

Meta-analysis of Risk Reduction Estimates Associated With Risk-Reducing Salpingo-oophorectomy in BRCA1 or BRCA2 Mutation Carriers

CDH1 on Multigene Panel Testing: Look Before You Leap

Therapeutic approaches for women predisposed to breast cancer

Comparison of up-front cash cards and checks as incentives for participation in a clinician survey: a study within a trial

Toward Application of Polygenic Risk Scores to Both Enhance and Deintensify Breast Cancer Screening

Stumbling blocks on the path to personalized medicine in breast cancer: the case of PARP inhibitors for BRCA1/2-associated cancers

Population Frequency of Germline BRCA1/2 Mutations

Aktive Filter

Suchergebnisse filtern